Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Xuan Huang, MD

Xuan Huang, MD

  • Specialty: Oncology and Hematology
    View Expertise
  • Primary Location: 41201 Schadden Rd (28 mi.)
    Other Locations
  • Languages Spoken: English, Chinese

Office Locations

American Oncology Partners, PA (28 mi.)

41201 Schadden Rd
STE 2
Elyria, OH 44035
440-324-0401

Biography: Xuan Huang, MD

Expertise

  • Benign Hematology
  • Breast Cancer
  • Coagulation Disorders
  • Colon and Rectal Cancer
  • Gastrointestinal Cancers
  • Genitourinary Cancer
  • Lung Cancer
  • Lymphoma
  • Malignant Hematology
  • Melanoma
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Neuroendocrine Malignancies

Titles

  • Clinical Assistant Professor, CWRU School of Medicine

Education

Fellowship | Hematology
Hematology - National Heart, Lung, And Blood Institute (2011 - 2011)

Fellowship | Medical Oncology
Medical Oncology - National Cancer Institute (Nci) (2009 - 2012)

Residency | Internal Medicine
Internal Medicine - Richmond University Medical Center (2006 - 2009)

Observership | Hematology/Oncology
Hematology/Oncology - Westchester Medical Center (2005 - 2006)

Other Education
New York Medical College (1999 - 2006)

Other Education
Beijing Medical University (1999)

Medical Education
Beijing Medical University (1999)

UH Quality Care Network, is a collaboration among independent and UH employed providers. The focus is on improving the quality and efficiency of care, as well as reducing the cost of care.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Xuan Huang did not disclose any Outside Relationships with Industry.